Abstract
BackgroundThe introduction of biosimilars has been linked with concerns regarding how to best monitor their similarity vs. the originator product using real world data.MethodsData from the Swedish Rheumatology Quality register...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
